Evercore ISI Group Maintains Outperform on Abbott Laboratories, Raises Price Target to $120

Benzinga · 1d ago
Evercore ISI Group analyst Vijay Kumar maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $112 to $120.